1177 · Sino Biopharmaceutical Limited

5.60

HKD

0.21 (3.80%)

21/08/2026 12:00:00 AM

Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

HK$100.70B

43.80

EV/EBITDA

13.5

DIV Yield

1.6%

Payout Ratio

71%

MQV Rating

3Neutral

As at 21/08/2026 12:00:00 AM

Price Chart

Description

Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Investment, Modernised Chinese Medicines and Chemical Medicines; and Others. The Investment segment offers long-term investments. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products. The Investment segment offers long-term investments. The Other segment includes a research and development sector, which provides services to third parties; and related healthcare and hospital business. It also develops medicines for treating tumors, analgesia, diabetes, and respiratory system diseases. The company was founded by Ping Tse Cheung Ling Cheng and on February 2, 2000, and is headquartered in Hong Kong.

All-Companies
All-Consensus
ALL-Recommendations
Big Candle
Consensus Cheap
HALO 100
HALO 200
HALO All
Recent Earnings upgrade
Volume Spike

Key Fundamentals

EPS 3 yr Growth

-4.70%

EBITDA Margin

25.10%

Operating Cashflow

¥11,392m

Free Cash Flow Return

31.30%

ROIC

6.40%

Interest Coverage

28.70

Quick Ratio

1.30

Performance

52 weeks range

Low 4.19 - 9.12

Trade Value (12mth)

US$17,652,741.00

1 week

10.68%

1 month

3.85%

YTD

-15.25%

1 year

-30.09%

All time high

11.24

Additional Data

Shares Outstanding (Fully Diluted)

18,050m

HALO Sector

Healthcare

Next Company Report Date

01-Apr-27

Next Ex Dividend Date

01-Sep-26

Next Dividend Pay Date

24-Sep-26

Reporting Currency

CNY

Short Sell (% of issue)

0.00

Consensus

Unlock full consensus

Consensus score

/10

Recommendation

Buy

Target price

Deviation

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Neutral

Garp

Strong

Mqv Small

Neutral

Momentum

Price

Strong

Earnings

Neutral

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Strong

Balance Sheet

Neutral

Valuation

Unlock full dataset

Value

Consensus

Yield

News & Announcements

No announcements available.

Key Stakeholders

Name	Title
S Y Tse	Individual
Cheung Ling Cheng	Individual
Ping Tse	Individual
Hsin Tse	Individual
Invesco Great Wall Fund Management Co. Ltd.	Joint Venture

Related Companies

View all

2359 · WuXi AppTec Co., Ltd. Class H

205.8HK$

603259 · WuXi AppTec Co., Ltd. Class A

167.9Yuan

1276 · Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H

48.2HK$

1177 · Sino Biopharmaceutical Limited

5.60

Overview

HK$100.70B

43.80

13.5

1.6%

71%

3Neutral

Price Chart

Description

Key Fundamentals

Performance

Additional Data

Consensus

Health Scores

Short Term

Halo Model

Momentum

Growth

Quality

Valuation

News & Announcements

Key Stakeholders

Related Companies

See beyond the curve.